These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5626248)

  • 21. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis of hepatosis].
    Nöcker J; Hartleb O; Weidemann H
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):349-54. PubMed ID: 5998358
    [No Abstract]   [Full Text] [Related]  

  • 24. [Should we do a liver puncture biopsy in patients with chronic "unexplained" cytolyses?].
    De Lédinghen V
    Gastroenterol Clin Biol; 2002; 26(8-9):724-7. PubMed ID: 12434076
    [No Abstract]   [Full Text] [Related]  

  • 25. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 26. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
    Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electron microscopy in the diagnostics of liver diseases.
    Satler J
    Acta Hepatosplenol; 1968; 15(2):72-7. PubMed ID: 5670008
    [No Abstract]   [Full Text] [Related]  

  • 28. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
    Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic evaluation of nonalcoholic fatty liver disease.
    Adams LA; Talwalkar JA
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S34-8. PubMed ID: 16540765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential diagnosis of the diabetic and alcoholic fatty liver. Concluding remarks].
    Robbers H
    Dtsch Med Wochenschr; 1968 Aug; 93(33):1576. PubMed ID: 5662607
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contribution of liver biopsy and serology of hepatitis C virus to the diagnosis of a moderate and prolonged elevation of aminotransferases].
    Dao T; Lecointe I; Galateau F; Freymuth F; Rideau A; Verwaerde JC; Valla A
    Gastroenterol Clin Biol; 1993; 17(1):37-43. PubMed ID: 8467969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease and OGTT.
    Uygur-Bayramiçli O; Sargin M
    J Clin Gastroenterol; 2008 Feb; 42(2):219. PubMed ID: 18209601
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current problems of fatty liver].
    Knick B
    Dtsch Med J; 1968 May; 19(10):389-94. PubMed ID: 4889933
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-alcoholic steatohepatitis. Report of five cases and review of the literature.
    Conte D; Bolzoni P; Fraquelli M; Bodini P; Velio P
    Ital J Gastroenterol; 1995 Sep; 27(7):363-5. PubMed ID: 8563007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histologic spectrum of nonalcoholic fatty liver disease.
    Contos MJ; Choudhury J; Mills AS; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):481-500, vii. PubMed ID: 15331059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.